Published on | 2 years ago
Last updated on | 1 week ago
sarah.stroobants@fwo.be
With this pilot the Commission wants to tackle concerns that the evaluation process could be perceived as biased towards well-known organisations in countries with better performing Research and Innovation systems. The Commission indicates that a recent independent study has not revealed such a bias.
The pilot aims to identify whether the implementation of blind evaluation within the legal requirements and operational context creates any difficulties. If this is not the case, it might lead to a modified approach, with a greater use of blind evaluations, which could effectively mitigate the risk of real, potential or perceived reputational bias.
The recording of a Commission information webinar on the topic is available here. The slides used during this webinar can be found in attachment.
In the Horizon Europe Work Programme 2025,where provided for in the specific call/topic conditions, first-stage proposals of the two-stage call topics will be evaluated blindly. Note that in the Horizon Europe Work Programme 2023-2024, all first-stage proposals of two-stage call topics have also been evaluated blindly (except one call for Widening).
The concept of blind evaluation requires that experts evaluators do not know the consortium structure and the applicant(s) involved. To accomplish this, the following safeguards are in place:
Thus, applicants submitting a proposal under the blind evaluation pilot must take into account a new admissibility criterion: they must not disclose their organisation names, acronyms, logos nor names of personnel in the proposal abstract and Part B of their first-stage application (see General Annexes A &E). If identification as listed here above is mentioned by applicants in the proposal’s Part B, the proposal will be inadmissible.
The application form for stage 1 applications for topics under the blind evaluation pilot, includes a dedicated page with guidance for blind evaluations and annotations in the template text to guide applicants. The application form is provided with the relevant call topic in the online submission system on the Funding and Tenders Portal.
The following extract from the dedicated page with guidance for blind evaluations provides concrete examples:
In the different sections of the application form, annotations have been added to remind applicants to pay special attention not to expose their identity. Herewith two examples (Excellence part):
It is important to keep in mind that stage 1 will only assess the excellence and impact criteria, whereas the quality of the partners and of the consortium composition (including relevant previous publications, achievements & projects of the consortium partners) will be assessed only in stage 2. More details about the two-stage submission procedure are available in this dedicated infosheet.
The legal basis for this pilot can be found in Article 28 of the Horizon Europe Regulation:
Article 28 Award criteria and selection
[…] 4. The Commission and other funding bodies shall take into account the possibility of a two-stage submission and evaluation procedure and where appropriate, anonymised proposals may be evaluated during the first stage of evaluation based on one or more of the award criteria referred to in paragraph 1.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.